Mark T Szmanda, MD | |
2251 N Shore Dr, Rhinelander, WI 54501-6710 | |
(715) 361-2000 | |
Not Available |
Full Name | Mark T Szmanda |
---|---|
Gender | Male |
Speciality | Neurology |
Experience | 34 Years |
Location | 2251 N Shore Dr, Rhinelander, Wisconsin |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1912060971 | NPI | - | NPPES |
30063000 | Medicaid | WI |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2084N0400X | Psychiatry & Neurology - Neurology | 35650 (Wisconsin) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Ascension St Marys Hospital | Rhinelander, WI | Hospital |
Ascension Eagle River Hospital | Eagle river, WI | Hospital |
Howard Young Medical Center | Woodruff, WI | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Aspirus Rhinelander And Tomahawk Hospitals And Clinics Inc | 9335059856 | 309 |
News Archive
People with diabetes are at a greater risk for the development or progression of diabetic nephropathy if they have low levels of high-density lipoprotein cholesterol, report researchers.
A new study shows that exposure to bright light may ease symptoms of depression in elderly people. The researchers tried three weeks of bright light therapy using specially designed light boxes and saw that it improved symptoms of depression by as much as 54% in older adults with depression. The light therapy also improved sleep and optimized levels of the neurotransmitter serotonin. Low levels of serotonin are associated with depression and often targeted by antidepressant drugs. This is the first study of its kind to show a beneficial effect of bright light therapy on treating depression in the elderly with non-seasonal major depressive disorder.
Reveal Sciences, LLC, a cosmetics and aesthetics innovation company pioneering breakthrough skin care diagnostics, has announced the launch of the new consumer At-Home Skin Typing and Analysis Kit.
Researchers at Karolinska Institutet in Sweden have identified a new so-called pseudogene that regulates the tumour-suppressing PTEN gene. They hope that this pseudogene will be able to control PTEN to reverse the tumour process, make the cancer tumour more sensitive to chemotherapy and to prevent the development of resistance.
India has taken the lead to get together a number of generic drug-producing nations to call for better definitions to ensure quality, strengthening of regulatory authorities in the respective countries, and bringing focus of the world to public health instead of intellectual property, PHARMABIZ.com writes in an article that examines the recent meeting of leaders from Brazil, India and South Africa on issues regarding counterfeit medicines.
› Verified 9 days ago
Entity Name | Aspirus Rhinelander & Tomahawk Hospitals & Clinics Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1144991340 PECOS PAC ID: 9335059856 Enrollment ID: O20031126000706 |
News Archive
People with diabetes are at a greater risk for the development or progression of diabetic nephropathy if they have low levels of high-density lipoprotein cholesterol, report researchers.
A new study shows that exposure to bright light may ease symptoms of depression in elderly people. The researchers tried three weeks of bright light therapy using specially designed light boxes and saw that it improved symptoms of depression by as much as 54% in older adults with depression. The light therapy also improved sleep and optimized levels of the neurotransmitter serotonin. Low levels of serotonin are associated with depression and often targeted by antidepressant drugs. This is the first study of its kind to show a beneficial effect of bright light therapy on treating depression in the elderly with non-seasonal major depressive disorder.
Reveal Sciences, LLC, a cosmetics and aesthetics innovation company pioneering breakthrough skin care diagnostics, has announced the launch of the new consumer At-Home Skin Typing and Analysis Kit.
Researchers at Karolinska Institutet in Sweden have identified a new so-called pseudogene that regulates the tumour-suppressing PTEN gene. They hope that this pseudogene will be able to control PTEN to reverse the tumour process, make the cancer tumour more sensitive to chemotherapy and to prevent the development of resistance.
India has taken the lead to get together a number of generic drug-producing nations to call for better definitions to ensure quality, strengthening of regulatory authorities in the respective countries, and bringing focus of the world to public health instead of intellectual property, PHARMABIZ.com writes in an article that examines the recent meeting of leaders from Brazil, India and South Africa on issues regarding counterfeit medicines.
› Verified 9 days ago
Entity Name | Lakeside Neurocare Limited |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1710046404 PECOS PAC ID: 9032161443 Enrollment ID: O20050214000860 |
News Archive
People with diabetes are at a greater risk for the development or progression of diabetic nephropathy if they have low levels of high-density lipoprotein cholesterol, report researchers.
A new study shows that exposure to bright light may ease symptoms of depression in elderly people. The researchers tried three weeks of bright light therapy using specially designed light boxes and saw that it improved symptoms of depression by as much as 54% in older adults with depression. The light therapy also improved sleep and optimized levels of the neurotransmitter serotonin. Low levels of serotonin are associated with depression and often targeted by antidepressant drugs. This is the first study of its kind to show a beneficial effect of bright light therapy on treating depression in the elderly with non-seasonal major depressive disorder.
Reveal Sciences, LLC, a cosmetics and aesthetics innovation company pioneering breakthrough skin care diagnostics, has announced the launch of the new consumer At-Home Skin Typing and Analysis Kit.
Researchers at Karolinska Institutet in Sweden have identified a new so-called pseudogene that regulates the tumour-suppressing PTEN gene. They hope that this pseudogene will be able to control PTEN to reverse the tumour process, make the cancer tumour more sensitive to chemotherapy and to prevent the development of resistance.
India has taken the lead to get together a number of generic drug-producing nations to call for better definitions to ensure quality, strengthening of regulatory authorities in the respective countries, and bringing focus of the world to public health instead of intellectual property, PHARMABIZ.com writes in an article that examines the recent meeting of leaders from Brazil, India and South Africa on issues regarding counterfeit medicines.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Mark T Szmanda, MD 2251 N Shore Dr, Rhinelander, WI 54501-6710 Ph: (715) 361-2000 | Mark T Szmanda, MD 2251 N Shore Dr, Rhinelander, WI 54501-6710 Ph: (715) 361-2000 |
News Archive
People with diabetes are at a greater risk for the development or progression of diabetic nephropathy if they have low levels of high-density lipoprotein cholesterol, report researchers.
A new study shows that exposure to bright light may ease symptoms of depression in elderly people. The researchers tried three weeks of bright light therapy using specially designed light boxes and saw that it improved symptoms of depression by as much as 54% in older adults with depression. The light therapy also improved sleep and optimized levels of the neurotransmitter serotonin. Low levels of serotonin are associated with depression and often targeted by antidepressant drugs. This is the first study of its kind to show a beneficial effect of bright light therapy on treating depression in the elderly with non-seasonal major depressive disorder.
Reveal Sciences, LLC, a cosmetics and aesthetics innovation company pioneering breakthrough skin care diagnostics, has announced the launch of the new consumer At-Home Skin Typing and Analysis Kit.
Researchers at Karolinska Institutet in Sweden have identified a new so-called pseudogene that regulates the tumour-suppressing PTEN gene. They hope that this pseudogene will be able to control PTEN to reverse the tumour process, make the cancer tumour more sensitive to chemotherapy and to prevent the development of resistance.
India has taken the lead to get together a number of generic drug-producing nations to call for better definitions to ensure quality, strengthening of regulatory authorities in the respective countries, and bringing focus of the world to public health instead of intellectual property, PHARMABIZ.com writes in an article that examines the recent meeting of leaders from Brazil, India and South Africa on issues regarding counterfeit medicines.
› Verified 9 days ago
Jeffrey Paul Holmgren, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 705 E Timber Dr, Rhinelander, WI 54501 Phone: 715-362-7463 | |
Carol Barber, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1020 Kabel Ave, Rhinelander, WI 54501 Phone: 715-361-4700 | |
Richard E Immler, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 2251 N Shore Dr Ste 100, Rhinelander, WI 54501 Phone: 715-361-2000 | |
Mandeep Singh, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2251 North Shore Dr, Rhinelander, WI 54501 Phone: 715-361-2000 | |
Miles E O'hanlon, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 2251 N Shore Dr, Rhinelander, WI 54501 Phone: 715-361-4700 Fax: 715-361-4887 | |
Dr. Lisa A Wheeler, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2251 N Shore Dr, Rhinelander, WI 54501 Phone: 715-361-2000 | |
Dr. Meredith Ann Holbrook, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2251 North Shore Dr, Rhinelander, WI 54501 Phone: 715-361-2000 |